ATLASWerewolf Therapeutics (HOWL) earnings date: Nov 3, 2026
Werewolf Therapeutics (HOWL) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, before the open. Analysts expect EPS of -$0.22.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on HOWL
| Last price | $0.99 (-10.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.4% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Werewolf Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Werewolf Therapeutics reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Werewolf Therapeutics. You can switch it off at any time.
Alert me before HOWL reportsFree to start. Creating an account takes under a minute.
HOWL earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.22 |
| Last report | Jul 31, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +38.3% |
| Average move around a report | ±10.3% (last 5) |
| Sector | Healthcare · Biotechnology |
Werewolf Therapeutics earnings history: last 5 reports
Werewolf Therapeutics last reported on Jul 31, 2026: EPS of $0.14 against an estimate of -$0.32 (+143.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 31, 2026 | -$0.32 | $0.14 | +143.8% | Beat | -26.4% |
| May 7, 2026 | -$0.29 | -$0.28 | +3.4% | Beat | +4.6% |
| Mar 27, 2026 | -$0.35 | -$0.17 | +51.4% | Beat | -7.7% |
| Nov 28, 2025 | $2.94 | $2.57 | -12.6% | Miss | -6.1% |
| Nov 4, 2025 | -$0.38 | -$0.36 | +5.3% | Beat | -6.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for HOWL
See the fair value, the probability range and the earnings history of Werewolf Therapeutics on its ATLAS page.
Werewolf Therapeutics (HOWL) stock analysisPlans from €3.99 a month.
Werewolf Therapeutics earnings: frequently asked questions
When does Werewolf Therapeutics (HOWL) report earnings?
Werewolf Therapeutics is scheduled to report on Tuesday, November 3, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for HOWL?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.22 per share (USD). Estimates can change before the report.
How often does HOWL beat earnings estimates?
Of its last 5 reports with a recorded result, Werewolf Therapeutics beat the EPS estimate 4 times; the average surprise was +38.3%. Past results do not predict the next one.
How much does HOWL move around earnings?
Over its last 5 reports the stock moved an average of 10.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Werewolf Therapeutics beat earnings estimates last quarter?
Werewolf Therapeutics last reported on Jul 31, 2026: EPS of $0.14 against an estimate of -$0.32 (+143.8% surprise), a beat.
How much does HOWL usually move in a day?
On a normal trading day the ATLAS model puts HOWL’s one-day range at about ±5.4%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer